SecBot SecBot
DEFA14A ·Filed Apr 13, 2026

KYTX

Kyverna Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed6mo ago SEC0001193125-26-152870
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine shareholder meeting with no material financial decisions. Traders should monitor for any unexpected statements about company performance or strategy during the meeting, but the proposals themselves are standard governance matters.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
KYTX ▲ +4.81% at T+60d
NEUTRAL call +4.81% · α vs SPY -3.71% · entry $9.36 → $9.81
Entry = T+0 close
Apr 13, 2026
via day close
T+1d
+0.43%
call +0.43% · α -0.35%
$9.40
settled 7mo ago
T+5d
+3.74%
call +3.74% · α +2.35%
$9.71
settled 6mo ago
T+20d
+10.47%
call +10.47% · α +4.17%
$10.34
settled 6mo ago
T+60d
+4.81%
call +4.81% · α -3.71%
$9.81
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Kyverna Therapeutics, Inc. (KYTX) is holding its 2026 Annual Meeting to elect two Class II directors and ratify the appointment of BDO USA, P.C. as its independent registered public accounting firm. The board recommends voting FOR both proposals.

Key Financial Metrics

Vote
director election
Meeting
2026-05-27
Seats Contested
2

Key Facts

  • KYTX is holding its 2026 Annual Meeting to elect two Class II directors: Ian Clark and Christi Shaw
  • The company is ratifying the appointment of BDO USA, P.C. as its independent registered public accounting firm for 2026
  • The board recommends voting FOR both proposals
  • The meeting will be held virtually on May 27, 2026

Financial Impact

Routine corporate governance matter with no immediate financial impact

governanceboard composition

Risk Factors

  • No significant risks identified from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-152870
Document: 0001193125-26-152870-index-headers.html0001193125-26-152870
Document: 0001193125-26-152870-index.html0001193125-26-152870
Document: 0001193125-26-152870.txt0001193125-26-152870
17 reports for KYTX
Performance horizon
33% Hit rate @ T+1 3 of 9 directional calls Went positive at some point 4 of 9 best @ T+20▲ +10.86%Mar 5, 2026
Filters
Rows
Reports for KYTX — sortable, filterable
TypeNow
Oct 19, 2026
7d ago
SC 13G
NEUTRAL ★ 4/10
$5.83 $6.04▲ +3.60%▲ +3.27%$5.44 (−6.69%)
Sep 24, 2026
4w ago
8-K
BULLISH ★ 7/10
$6.99 $6.81▼ −2.58%▼ −3.12%$5.44 (−22.17%)
Aug 11, 2026
10w ago
8-K
BULLISH ★ 6/10
$8.05 $8.08▲ +0.37%▼ −0.33%$5.44 (−32.42%)
Aug 11, 2026
10w ago
Press Release
NEUTRAL ★ 5/10
$8.05 $8.08▲ +0.37%▼ −0.33%$5.44 (−32.42%)
Jul 27, 2026
13w ago
8-K
NEUTRAL ★ 4/10
$7.92 $7.49▼ −5.43%▼ −5.67%$5.44 (−31.31%)
Jul 9, 2026
15w ago
8-K
NEUTRAL ★ 4/10
$9.81 $8.49▼ −13.51%▼ −13.94%$5.44 (−44.55%)
Jun 11, 2026
19w ago
Institutional Cluster
BEARISH ★ 5/10
$8.06 $8.15▼ −1.18%▲ +0.58%$5.44 (+32.46%)
May 4, 2026
25w ago
8-K
NEUTRAL ★ 2/10
$9.00 $9.21▲ +2.33%▲ +1.54%$5.44 (−39.56%)
Apr 22, 2026
26w ago
8-K
BULLISH ★ 7/10
$10.23 $8.95▼ −12.51%▼ −12.12%$5.44 (−46.82%)
Apr 20, 2026
27w ago
Press Release
BULLISH ★ 8/10
$11.25 $9.71▼ −13.69%▼ −13.04%$5.44 (−51.64%)
Showing 10 of 17

US Market Status

Market Open — Closes in 3h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 13, 2026